Bio-Rad Laboratories, Inc. (BIO)
Medical - Devices · Healthcare · $7.6B
Intrinsic Value (Consensus)
$107.10
Current Price
$282.48
Margin of Safety
-62.1%
62.1% Above Intrinsic Value
Value: $107
Price: $282
Valuation Model Estimates
Current Price: $282.48
DCF (Discounted Cash Flow)
$57.74
Graham Number
$193.17
Earnings Power Value
$56.09
Relative Value (P/E)
$121.40
Dividend Discount Model
Not applicable
—
Consensus Value
$107.10
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
56
Profitability
18/25
Strength
24/25
Valuation
7/25
Growth
7/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $6.07
- EPS (Forward)
- $6.19
- Book Value
- $273.22
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 10.2%
- Debt/Equity
- 16%
- Revenue Growth
- 0.7%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.09
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance